Share subscriptions based on Nanoform Finland Plc’s stock options 2-3/2019 and 1/2020
Company release Nanoform Finland Plc September 6, 2022 06:00 p.m.…
Nanoform Q2 and H1 2022 report: Strong momentum continues
Company Announcement Nanoform Finland Plc August 25, 2022 08:10 a.m.…
Podcast : Empowering a New Era of Patient-Centric Medicines With Nanoform Technologies
Christian Jones Chief Commercial Officer at Nanoform discusses what it truly means…
Invitation to Nanoform’s Interim Report January-June 2022
Press release Nanoform Finland Plc August 10th, 2022 11:00 a.m.…
Article : Embracing GMP Manufacturing to Meet Pharma’s Future
The pharma industry is looking to novel technologies for answers…